A comparative study of CD34+ cells, CD34+ subsets, colony forming cells and cobblestone area forming cells in cord blood and bone marrow allografts.

K Theilgaard-Mönch; K Raaschou-Jensen; C Heilmann; H Andersen; J Bock; C A Russel; L Vindeløv; N Jacobsen; E Dickmeiss

A comparative study of CD34+ cells, CD34+ subsets, colony forming cells and cobblestone area forming cells in cord blood and bone marrow allografts.

K Theilgaard-Mönch, K Raaschou-Jensen, C Heilmann, H Andersen, J Bock, C A Russel, L Vindeløv, N Jacobsen, E Dickmeiss

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

13 Citationer (Scopus)

Abstract

Udgivelsesdato: 1999-Mar

Originalsprog	Engelsk
Tidsskrift	European Journal of Haematology
Vol/bind	62
Udgave nummer	3
Sider (fra-til)	174-83
Antal sider	9
ISSN	0902-4441
Status	Udgivet - 1999
Udgivet eksternt	Ja

Bibliografisk note

Keywords: ADP-ribosyl Cyclase; Adult; Antigens, CD; Antigens, CD34; Antigens, CD38; Antigens, Differentiation; Bone Marrow Transplantation; Cell Count; Cell Separation; Colony-Forming Units Assay; Female; Fetal Blood; Flow Cytometry; Hematopoietic Stem Cell Transplantation; Humans; Male; Membrane Glycoproteins; Middle Aged; NAD+ Nucleosidase; Predictive Value of Tests; Reproducibility of Results; Transplantation, Homologous

Citationsformater

@article{0260f56058b011dd8d9f000ea68e967b,

title = "A comparative study of CD34+ cells, CD34+ subsets, colony forming cells and cobblestone area forming cells in cord blood and bone marrow allografts.",

abstract = "Cord blood (CB) has become an alternative source of hematopoietic progenitor cells (HPCs) for allogeneic transplantation. We have developed a new efficient protocol for CB collection. Using this method an average of 17.7 x 10(8) [range (6.8-29.6) x 10(8), n = 13] total nucleated cells (TNCs) were harvested. Based on recent Eurocord data, which have shown safe engraftment using a threshold dose of 0.37 x 10(8) CB TNCs/kg body weight (BW), we calculated that six out of thirteen CB grafts collected by this method were sufficient to engraft adults. The CB derived CD34+ population contained two-fold higher numbers of committed HPCs (CFU-GM, BFU-E) and six-fold higher numbers of pluripotent HPCs [CD34+/CD38- cells, wk 5 and wk 8 cobblestone area forming cells (CAFCs)] than the CD34+ population of BM. Extrapolation revealed that BM grafts providing the threshold dose for allogeneic transplantation of 2 x 10(8) TNCs/kg BW contained nearly 3 times more pluripotent HPCs than CB grafts providing the Eurocord threshold dose. The assessment of CD34+/CD38(-) cell numbers in CB grafts was highly reproducible and correlated well with the in vitro performance of pluripotent HPCs, i.e. numbers of CAFCs. We conclude that CB grafts providing high numbers of TNCs have the potential to engraft adults and that the enumeration of pluripotent HPCs by flow cytometry may be a useful tool to define the ultimate threshold dose for CB transplantation.",

author = "K Theilgaard-M{\"o}nch and K Raaschou-Jensen and C Heilmann and H Andersen and J Bock and Russel, {C A} and L Vindel{\o}v and N Jacobsen and E Dickmeiss",

note = "Keywords: ADP-ribosyl Cyclase; Adult; Antigens, CD; Antigens, CD34; Antigens, CD38; Antigens, Differentiation; Bone Marrow Transplantation; Cell Count; Cell Separation; Colony-Forming Units Assay; Female; Fetal Blood; Flow Cytometry; Hematopoietic Stem Cell Transplantation; Humans; Male; Membrane Glycoproteins; Middle Aged; NAD+ Nucleosidase; Predictive Value of Tests; Reproducibility of Results; Transplantation, Homologous",

year = "1999",

language = "English",

volume = "62",

pages = "174--83",

journal = "European Journal of Haematology",

issn = "0902-4441",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - A comparative study of CD34+ cells, CD34+ subsets, colony forming cells and cobblestone area forming cells in cord blood and bone marrow allografts.

AU - Theilgaard-Mönch, K

AU - Raaschou-Jensen, K

AU - Heilmann, C

AU - Andersen, H

AU - Bock, J

AU - Russel, C A

AU - Vindeløv, L

AU - Jacobsen, N

AU - Dickmeiss, E

N1 - Keywords: ADP-ribosyl Cyclase; Adult; Antigens, CD; Antigens, CD34; Antigens, CD38; Antigens, Differentiation; Bone Marrow Transplantation; Cell Count; Cell Separation; Colony-Forming Units Assay; Female; Fetal Blood; Flow Cytometry; Hematopoietic Stem Cell Transplantation; Humans; Male; Membrane Glycoproteins; Middle Aged; NAD+ Nucleosidase; Predictive Value of Tests; Reproducibility of Results; Transplantation, Homologous

PY - 1999

Y1 - 1999

N2 - Cord blood (CB) has become an alternative source of hematopoietic progenitor cells (HPCs) for allogeneic transplantation. We have developed a new efficient protocol for CB collection. Using this method an average of 17.7 x 10(8) [range (6.8-29.6) x 10(8), n = 13] total nucleated cells (TNCs) were harvested. Based on recent Eurocord data, which have shown safe engraftment using a threshold dose of 0.37 x 10(8) CB TNCs/kg body weight (BW), we calculated that six out of thirteen CB grafts collected by this method were sufficient to engraft adults. The CB derived CD34+ population contained two-fold higher numbers of committed HPCs (CFU-GM, BFU-E) and six-fold higher numbers of pluripotent HPCs [CD34+/CD38- cells, wk 5 and wk 8 cobblestone area forming cells (CAFCs)] than the CD34+ population of BM. Extrapolation revealed that BM grafts providing the threshold dose for allogeneic transplantation of 2 x 10(8) TNCs/kg BW contained nearly 3 times more pluripotent HPCs than CB grafts providing the Eurocord threshold dose. The assessment of CD34+/CD38(-) cell numbers in CB grafts was highly reproducible and correlated well with the in vitro performance of pluripotent HPCs, i.e. numbers of CAFCs. We conclude that CB grafts providing high numbers of TNCs have the potential to engraft adults and that the enumeration of pluripotent HPCs by flow cytometry may be a useful tool to define the ultimate threshold dose for CB transplantation.

AB - Cord blood (CB) has become an alternative source of hematopoietic progenitor cells (HPCs) for allogeneic transplantation. We have developed a new efficient protocol for CB collection. Using this method an average of 17.7 x 10(8) [range (6.8-29.6) x 10(8), n = 13] total nucleated cells (TNCs) were harvested. Based on recent Eurocord data, which have shown safe engraftment using a threshold dose of 0.37 x 10(8) CB TNCs/kg body weight (BW), we calculated that six out of thirteen CB grafts collected by this method were sufficient to engraft adults. The CB derived CD34+ population contained two-fold higher numbers of committed HPCs (CFU-GM, BFU-E) and six-fold higher numbers of pluripotent HPCs [CD34+/CD38- cells, wk 5 and wk 8 cobblestone area forming cells (CAFCs)] than the CD34+ population of BM. Extrapolation revealed that BM grafts providing the threshold dose for allogeneic transplantation of 2 x 10(8) TNCs/kg BW contained nearly 3 times more pluripotent HPCs than CB grafts providing the Eurocord threshold dose. The assessment of CD34+/CD38(-) cell numbers in CB grafts was highly reproducible and correlated well with the in vitro performance of pluripotent HPCs, i.e. numbers of CAFCs. We conclude that CB grafts providing high numbers of TNCs have the potential to engraft adults and that the enumeration of pluripotent HPCs by flow cytometry may be a useful tool to define the ultimate threshold dose for CB transplantation.

M3 - Journal article

C2 - 10089895

SN - 0902-4441

VL - 62

SP - 174

EP - 183

JO - European Journal of Haematology

JF - European Journal of Haematology

IS - 3

ER -